title: Bimatoprost in the treatment of eyelash hypotrichosis.
abstract: Eyelashes hypotrichosis is a condition indicated by an inadequate amount of eyelashes. Hypertrichosis of eyelashes, characterized by excessive eyelash growth, is a regular phenomenon associated with ophthalmic prostaglandin and prostamide analogs. Recently, the US Food and Drug Administration approved Latisse((R)) (bimatoprost 0.03% solution), identical to the ophthalmic solution for glaucoma treatment, for increasing eyelash length, thickness and darkness in patients with hypotrichosis of the eyelashes. When prostaglandin and prostamide analogs interact with the prostanoid receptors in the hair follicle, this most likely stimulates the resting follicles (telogen phase) to growing follicles (anagen phase). Prostaglandin and prostamide analogs may also prolong the anagen phase of eyelashes, leading to an increase of eyelash length. Although bimatoprost is effective in promoting increased growth of healthy eyelashes and adnexal hairs, its effectiveness in patients with eyelash alopecia areata is debatable and its protective effect is not yet studied in patients with eyelash loss secondary to radiation or chemotherapy. Bimatoprost is generally safe when applied to the base of the eyelashes at the lid margin with minimum side effects. However, other ocular or systemic side effects associated with ophthalmic prostaglandin and prostamide analogs may occur when instilled on the surface of the eye, and patients must be informed and monitored.
authors.affiliation: Jules Stein Eye Institute, University of California, Los Angeles, California, USA. law@jsei.ucla.edu
authors.forename: Simon K
authors.initials: SK
authors.lastname: Law
references.citation: Am J Ophthalmol. 1997 Oct;124(4):544-7
references.pmid: 9323945
references.citation: JAMA. 1979 Jul 13;242(2):142
references.pmid: 448883
references.citation: Vitam Horm. 2009;81:469-85
references.pmid: 19647123
references.citation: Arch Ophthalmol. 2001 Jul;119(7):994-1000
references.pmid: 11448321
references.citation: Ophthalmology. 2001 Jun;108(6):1023-31; discussion 1032
references.pmid: 11382623
references.citation: Am J Ophthalmol. 2003 May;135(5):688-703
references.pmid: 12719078
references.citation: J Cataract Refract Surg. 2003 Nov;29(11):2242-3
references.pmid: 14670442
references.citation: Ophthalmology. 2005 Feb;112(2):262-6
references.pmid: 15691561
references.citation: Biochem Biophys Res Commun. 2002 Jan 18;290(2):696-700
references.pmid: 11785955
references.citation: Arch Ophthalmol. 2000 May;118(5):718-9
references.pmid: 10815168
references.citation: Arch Ophthalmol. 2005 Nov;123(11):1541-6
references.pmid: 16286616
references.citation: N Engl J Med. 1999 Aug 12;341(7):491-7
references.pmid: 10441606
references.citation: Acta Derm Venereol. 2002;82(1):7-12
references.pmid: 12013211
references.citation: Surv Ophthalmol. 2001 May;45 Suppl 4:S353-60
references.pmid: 11434938
references.citation: J Ocul Pharmacol Ther. 2003 Jun;19(3):233-45
references.pmid: 12828841
references.citation: J Drugs Dermatol. 2004 Sep-Oct;3(5):571-2
references.pmid: 15552614
references.citation: Exp Dermatol. 2008 Jan;17(1):63-72
references.pmid: 18005048
references.citation: J Invest Dermatol. 1993 Jul;101(1 Suppl):135S-137S
references.pmid: 8326147
references.citation: Arch Ophthalmol. 1997 Sep;115(9):1206-8
references.pmid: 9298071
references.citation: Am J Ophthalmol. 2001 Oct;132(4):472-84
references.pmid: 11589866
references.citation: Adv Ther. 2001 May-Jun;18(3):110-21
references.pmid: 11571823
references.citation: Am J Ophthalmol. 2003 Jan;135(1):55-63
references.pmid: 12504698
references.citation: Am J Ophthalmol. 2005 May;139(5):932-3
references.pmid: 15860312
references.citation: Ophthalmic Plast Reconstr Surg. 2008 Jul-Aug;24(4):302-7
references.pmid: 18645437
references.citation: Eur J Ophthalmol. 2006 Mar-Apr;16(2):247-50
references.pmid: 16703542
references.citation: Clin Exp Dermatol. 2010 Jun;35(4):e161-2
references.pmid: 19925481
references.citation: Endocr Rev. 2000 Aug;21(4):363-92
references.pmid: 10950157
references.citation: Nurs Womens Health. 2009 Jun;13(3):243-8
references.pmid: 19523139
references.citation: Int J Radiat Biol. 1992 Apr;61(4):533-7
references.pmid: 1349335
references.citation: Br J Pharmacol. 2008 Jul;154(5):1079-93
references.pmid: 18587449
references.citation: Ophthalmology. 2006 Nov;113(11):1961-7
references.pmid: 16935336
references.citation: Med Biol Eng Comput. 1979 May;17(3):333-6
references.pmid: 317330
references.citation: Am J Ophthalmol. 2003 May;135(5):713-5
references.pmid: 12719085
references.citation: Comput Methods Programs Biomed. 2007 Aug;87(2):93-103
references.pmid: 17576020
references.citation: Am J Ophthalmol. 2005 Jan;139(1):202-3
references.pmid: 15652856
references.citation: J Eur Acad Dermatol Venereol. 2004 Sep;18(5):644-5
references.pmid: 15324422
references.citation: Arch Ophthalmol. 2001 Feb;119(2):300-1
references.pmid: 11176999
references.citation: Br J Pharmacol. 2008 Feb;153(3):410-9
references.pmid: 17721551
references.citation: Curr Probl Dermatol. 1984;12:1-58
references.pmid: 6209067
references.citation: Am J Ophthalmol. 2004 May;137(5):966-8
references.pmid: 15126179
references.citation: Am J Ophthalmol. 2003 Mar;135(3):314-20
references.pmid: 12614748
references.citation: Am J Ophthalmol. 2006 Dec;142(6):1059-60
references.pmid: 17157592
references.citation: Ophthalmology. 2007 Jul;114(7):1255-8
references.pmid: 17306877
references.citation: J Invest Dermatol. 1991 Aug;97(2):264-8
references.pmid: 1830074
references.citation: Clin Dermatol. 1988 Oct-Dec;6(4):119-21
references.pmid: 3214817
references.citation: J Am Acad Dermatol. 2001 Apr;44(4):721-3
references.pmid: 11260563
references.citation: Invest Ophthalmol Vis Sci. 2001 May;42(6):1134-45
references.pmid: 11328719
references.citation: Ocul Immunol Inflamm. 2003 Mar;11(1):67-71
references.pmid: 12854029
references.citation: Invest Ophthalmol Vis Sci. 2007 Sep;48(9):4123-8
references.pmid: 17724196
references.citation: Klin Monbl Augenheilkd. 2008 May;225(5):443-5
references.pmid: 18454393
references.citation: Surv Ophthalmol. 2001 May;45 Suppl 4:S337-45
references.pmid: 11434936
references.citation: Ophthalmic Plast Reconstr Surg. 2004 Jul;20(4):320-2
references.pmid: 15266150
references.citation: Ophthalmic Plast Reconstr Surg. 1997 Mar;13(1):21-5
references.pmid: 9076779
references.citation: Am J Ophthalmol. 2001 Jul;132(1):114-6
references.pmid: 11438068
references.citation: Am J Ophthalmol. 1999 May;127(5):602-4
references.pmid: 10334356
references.citation: Horm Res. 2000;54(5-6):243-50
references.pmid: 11595812
references.citation: Surv Ophthalmol. 2001 May;45 Suppl 4:S361-8
references.pmid: 11434939
references.citation: Acta Ophthalmol Scand. 1999 Dec;77(6):668-72
references.pmid: 10634560
references.citation: Br J Dermatol. 2010 Feb 1;162(2):304-10
references.pmid: 19804590
references.citation: Am J Ophthalmol. 2004 Apr;137(4):756-7
references.pmid: 15059720
references.citation: Pediatrics. 2005 Jan;115(1):e86-91
references.pmid: 15629970
references.citation: Surv Ophthalmol. 2002 Aug;47 Suppl 1:S185-202
references.pmid: 12204716
references.citation: Am J Ophthalmol. 1999 May;127(5):531-6
references.pmid: 10334345
references.citation: Ann Pharmacother. 1998 Apr;32(4):504-5
references.pmid: 9562149
references.citation: J Am Acad Dermatol. 2009 Sep;61(3):530-2
references.pmid: 19700021
references.citation: J Eur Acad Dermatol Venereol. 2007 Mar;21(3):421-3
references.pmid: 17309487
references.citation: Am J Ophthalmol. 2004 May;137(5):965-6
references.pmid: 15126178
references.citation: J Pharmacol Exp Ther. 2003 May;305(2):772-85
references.pmid: 12606640
references.citation: J Am Acad Dermatol. 2004 Nov;51(5):843
references.pmid: 15523378
references.citation: Arch Ophtalmol (Paris). 1977;37(11):697-708
references.pmid: 147666
references.citation: Ophthalmology. 1998 Feb;105(2):263-8
references.pmid: 9479285
references.citation: J Invest Dermatol. 1997 Feb;108(2):205-9
references.pmid: 9008235
references.citation: Arch Dermatol. 1969 Sep;100(3):328-35
references.pmid: 5822379
references.citation: Am J Ophthalmol. 2002 Mar;133(3):401-3
references.pmid: 11860979
references.citation: Rev Physiol Biochem Pharmacol. 2008;160:1-24
references.pmid: 18481028
references.citation: J Am Acad Dermatol. 2009 Apr;60(4):705-6
references.pmid: 19293023
references.citation: BMJ. 2001 Oct 6;323(7316):783
references.pmid: 11588081
references.citation: Jpn J Ophthalmol. 2009 Mar;53(2):176-179
references.pmid: 19333704
references.citation: Exp Dermatol. 2005 May;14(5):323-8
references.pmid: 15854125
references.citation: J Neuroendocrinol. 2008 May;20 Suppl 1:1-9
references.pmid: 18426492
references.citation: Eye (Lond). 2003 Apr;17(3):444-6
references.pmid: 12724722
references.citation: Br J Dermatol. 2006 Dec;155(6):1170-6
references.pmid: 17107385
references.citation: Optom Vis Sci. 2004 Aug;81(8):574-7
references.pmid: 15300114
references.citation: Am J Ophthalmol. 2004 Aug;138(2):305-6
references.pmid: 15289149
references.citation: Exp Dermatol. 2007 Sep;16(9):762-9
references.pmid: 17697149
references.citation: Indian J Ophthalmol. 2006 Mar;54(1):47-8
references.pmid: 16531673
references.citation: Exp Eye Res. 2003 Dec;77(6):721-30
references.pmid: 14609560
references.citation: Am J Ophthalmol. 1998 Jul;126(1):37-41
references.pmid: 9683147
references.citation: Surv Ophthalmol. 1997 Feb;41 Suppl 2:S129-38
references.pmid: 9154289
references.citation: Nippon Ganka Gakkai Zasshi. 2006 Aug;110(8):581-7
references.pmid: 16972649
references.citation: Int J Radiat Oncol Biol Phys. 1992;23(2):333-7
references.pmid: 1587754
references.citation: Int J Dermatol. 1995 Mar;34(3):149-58
references.pmid: 7751086